Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harish Pant

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Physical Chemistry. B|September 19, 2013
Specific and non-specific protein association in solution: computation of solvent effects and prediction of first-encounter modes for efficient configurational bias Monte Carlo simulationsAntonio Cardone, Harish Pant, Sergio A Hassan
Biology Open|November 22, 2017
Assembly and turnover of neurofilaments in growing axonal neuritesEdward F Boumil, Rishel Vohnoutka, Sangmook Lee, et al.
The American Journal of Tropical Medicine and Hygiene|July 9, 2024
Case Report: Multiple Metastatic Primary Multidrug-Resistant Tubercular AbscessesMegha Priyadarshi, Harish Pant, Sunit Sikdar, et al.
Leukemia Research Reports|December 24, 2025
Impact of Rituximab Maintenance on outcomes in Follicular Lymphoma: An indian experienceHarish Pant, Ajay Gogia, Atul Sharma, et al.
Current Research in Neurobiology|October 17, 2022
Therapeutic effects of TP5, a Cdk5/p25 inhibitor, in <i>in vitro</i> and <i>in vivo</i> models of Parkinson's diseaseJudith Tran, Shane K B Taylor, Anika Gupta, et al.
International Journal of Molecular Sciences|July 29, 2023
TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal CarcinomaNiranjana Amin, Herui Wang, Qi Song, et al.
Current Protocols|October 22, 2021
Protocols for Characterization of Cdk5 Kinase ActivityAnita Terse, Niranjana Amin, Bradford Hall, et al.
Cancers|July 26, 2020
TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against GlioblastomaEmeline Tabouret, Herui Wang, Niranjana Amin, et al.
Cancers|October 16, 2025
Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. <i>Cancers</i> 2020, <i>12</i>, 1935Emeline Tabouret, Herui Wang, Niranjana Amin, et al.
The International Journal of Biochemistry & Cell Biology|December 10, 2015
Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cellsCrismita Dmello, Sharada Sawant, Hunain Alam, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Physical Chemistry. B|September 19, 2013
Specific and non-specific protein association in solution: computation of solvent effects and prediction of first-encounter modes for efficient configurational bias Monte Carlo simulationsAntonio Cardone, Harish Pant, Sergio A Hassan
Biology Open|November 22, 2017
Assembly and turnover of neurofilaments in growing axonal neuritesEdward F Boumil, Rishel Vohnoutka, Sangmook Lee, et al.
The American Journal of Tropical Medicine and Hygiene|July 9, 2024
Case Report: Multiple Metastatic Primary Multidrug-Resistant Tubercular AbscessesMegha Priyadarshi, Harish Pant, Sunit Sikdar, et al.
Leukemia Research Reports|December 24, 2025
Impact of Rituximab Maintenance on outcomes in Follicular Lymphoma: An indian experienceHarish Pant, Ajay Gogia, Atul Sharma, et al.
Current Research in Neurobiology|October 17, 2022
Therapeutic effects of TP5, a Cdk5/p25 inhibitor, in <i>in vitro</i> and <i>in vivo</i> models of Parkinson's diseaseJudith Tran, Shane K B Taylor, Anika Gupta, et al.
International Journal of Molecular Sciences|July 29, 2023
TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal CarcinomaNiranjana Amin, Herui Wang, Qi Song, et al.
Current Protocols|October 22, 2021
Protocols for Characterization of Cdk5 Kinase ActivityAnita Terse, Niranjana Amin, Bradford Hall, et al.
Cancers|July 26, 2020
TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against GlioblastomaEmeline Tabouret, Herui Wang, Niranjana Amin, et al.
Cancers|October 16, 2025
Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. <i>Cancers</i> 2020, <i>12</i>, 1935Emeline Tabouret, Herui Wang, Niranjana Amin, et al.
The International Journal of Biochemistry & Cell Biology|December 10, 2015
Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cellsCrismita Dmello, Sharada Sawant, Hunain Alam, et al.
Pageof 1